Sigma Tau Pharmaceuticals Inc. changes its name to Leadiant Biosciences Inc.

Sigma-Tau Pharmaceuticals, Inc., a leader in the development and commercialization of medicines for patients with rare diseases, announced that the company has changed its name to Leadiant Biosciences, Inc. reaffirming the company�s continued strong commitment to the patient communities it serves.Leadiant Biosciences, Inc. is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical company dedicated to the development and commercialization of medicines for patients with rare diseases. Based in Gaithersburg, Maryland, Leadiant Biosciences, Inc. dedicates considerable scientific and financial resources to the research, development, and distribution of novel and effective therapies that address patient needs and improve quality of life.